Adenosine for heart protection during bypass surgery
Part of Heart & circulation clinical trials.
This study tests whether adding a medication called adenosine to the heart-protection solution used during heart surgery helps protect the heart better. If you are having a planned valve replacement or coronary bypass, this could potentially improve your recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for a planned (elective) heart surgery that is either a valve replacement or a coronary artery bypass (also called CABG).
- You have not had heart surgery before.
- You do not have chronic kidney disease (with a creatinine level above 2.0 mg/dL).
- You do not have a severe psychiatric illness that would interfere with the study.
- Your surgery is not urgent or emergency, and you are not having more than one heart procedure at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different solutions used to protect the heart during bypass surgery. The goal is to see which one causes less damage to the heart muscle, which could help you recover better after surgery.
This study tests whether giving a medication called adenosine before emergency heart catheterization (a tube procedure to open blocked arteries) helps patients having a heart attack. Adenosine may protect heart tissue and improve outcomes.
This study compares two ways of giving a medicine called adenosine during a heart procedure to check how well the small blood vessels in your heart work. Adenosine helps doctors see if these tiny vessels are functioning properly, and the study aims to find which method is better.
This study looks at a treatment that affects signals between heart cells in people with severe coronary artery disease who are scheduled for bypass surgery. The goal is to see if changing these heart-cell signals can improve heart outcomes around the time of surgery.
This study tests an experimental drug (ADR-002K) for people with heart failure caused by blocked arteries who are about to have bypass surgery. The goal is to see if it helps the heart recover better after surgery.
This trial studies a sustainable anesthesia approach for people having planned coronary artery bypass graft surgery (a type of open-heart surgery to improve blood flow to the heart). It aims to see if this method is safe and effective for patients at the study hospital.
Hear when a new Myocardial Protection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.